. However, a systematic evaluation of different reducing agents and temperature conditions for the conversion of NO 2 Ϫ and NO 3 Ϫ to NO has not been performed. We compared the efficiency of V(III), Mo(VI) ϩ Fe(II), NaI, Ti(III), and Cr(III) at different temperatures (20, 30, . . . 90°C) for the conversion of NO 2 Ϫ and (or) NO 3 Ϫ to NO. We also evaluated the recovery of NO 2 Ϫ and NO 3 Ϫ from plasmas of pig and of dog.
Nitric oxide (NO) is a free radical that reacts rapidly with several molecules in vitro or in vivo to form mainly nitrite (NO 2 Ϫ ) and nitrate (NO 3 Ϫ ). Interest in NO, NO 2 Ϫ , and NO 3 Ϫ measurements has increased exponentially with the discovery that NO or a chemically related compound plays a major role in vasodilation, inflammation, thrombosis, immunology, and neurotransmission [1] .
Measurements of NO 2
Ϫ and NO 3 Ϫ are also important in clinical chemistry as markers of nitric oxide synthase activity [2] .
Measurement of NO concentration in biological systems is a challenging analytical problem [3, 4] . The chemiluminescence detector-based method for trace NO 2 Ϫ and (or) NO 3 Ϫ in aqueous samples was first reported by Cox [5] and was later widely applied [6 -8] . This earliest and most commonly applied method is based on the conversion of NO 2 Ϫ to NO at room temperature by an acetic acid-sodium iodide (NaI) mixture. Ammonium molybdate [Mo(VI)] with ferrous ammonium sulfate [Fe(II)] in hot, 50% concentrated sulfuric acid was used for the reduction of both NO 2 Ϫ and NO 3 Ϫ to NO. NO 3 Ϫ was then determined as the difference of results obtained by the two methods. Vanadium (II) [V(II)] was mentioned as a possible reducing agent in the initial work by Cox [5] , who reported that it reduces NO 3 Ϫ to NO. Later work by Braman and Hendrix [9] indicated that it is V(III), not V(II), that reduces NO 3 Ϫ to NO. Stronger reducing agents such as chromium (II) [Cr(II)] and titanium (III) [Ti(III)] could also reduce NO 3 Ϫ to NO [10, 11] . However, a systematic evaluation of different reducing agents and temperature conditions for the conversion of NO 2 Ϫ and NO 3 Ϫ to NO has not been performed. We compared the efficiency of V(III), Mo(VI) ϩ Fe(II), NaI, Ti(III), and Cr(III) at different temperatures (20, 30, . . . 90°C) for the conversion of NO 2 Ϫ and (or) NO 3 Ϫ to NO. We also evaluated the recovery of NO 2 Ϫ and NO 3 Ϫ from plasmas of pig and of dog.
Materials and Methods
The NO concentration in samples was detected by chemiluminescence with a Sievers 270B NO analyzer (Sievers Instruments, Boulder, CO). The detector is based on the reaction of NO with ozone (O 3 ) to give nitrogen dioxide in an excited state (NO 2 *) plus molecular oxygen. The excited state of NO 2 * decays to give a weak infrared chemiluminescence above 600 nm. A microreaction purge vessel coupled with a condenser and heating jackets permitted introduction of the sample directly into the reduction solution via a gas-tight syringe (Hamilton, Reno, NV). The condenser jacket temperature was controlled by a continuous flow of cold water while the temperature of the heating jacket was controlled by a continuous flow of warm water regulated by a Haake constant-temperature circulating bath Model D1-L (Fisher Scientific, Montréal, QC, Canada). Nitrogen, at a rate of 100 mL/min, was used as the carrier gas of NO to the NO analyzer. The flow into the reaction chamber of the NO analyzer could be adjusted with a needle valve placed between the filter (Nupro Co., Willoughby, OH) and the NO analyzer. A MacLab data acquisition system (ADInstruments Pty, Castle Hill, NSW, Australia) was used to collect and report the data as area under the curve response from baseline to baseline [9] (Fig. 1) . We did not detect any NO 2 Ϫ or NO 3 Ϫ in the blanks used in this study.
reagents NO gas and nitrogen were purchased from Air Liquide (Canada), Montréal, QC, Canada. Vanadium trichloride, and sodium nitrite and nitrate were purchased from Aldrich Chemical Co. (Milwaukee, WI). Chromium trichloride, titanium trichloride, ferrous ammonium sulfate, ammonium molybdate, sodium iodide, and other reagents were purchased from Fisher Scientific. All were reagent-grade quality and used without further purification. High-purity distilled water was used in the preparation of all solutions.
recovery from aqueous solution 
recovery from plasma
We added known amounts (100, 200, . . . 500 pmol) of inorganic NO 2 Ϫ or NO 3 Ϫ in 0.1 mL of pig and dog plasma and then measured baseline amounts of NO 2 Ϫ and (or) NO 3 Ϫ to evaluate their recovery. Excessive foaming in the microreaction purge vessel caused by plasma proteins interfered with the reduction process. Therefore, all determinations in plasma samples were performed after deproteinization. Plasmas were diluted 10-fold with distilled water and deproteinized by addition of 1 ⁄20th volume of zinc sulfate to a final concentration of 15 g/L. After centrifugation at 1000g for 15 min, 0.1 mL of supernatant was applied to the microreaction purge vessel containing NaI solution at 30°C for the conversion of NO 2 Ϫ to NO, or V(III) solution at 80°C for the conversion of NO 3 Ϫ ϩ NO 2 Ϫ to NO. Samples of NO 2 Ϫ or NO 3 Ϫ added in plasma were compared with those prepared in distilled water in the same condition. This method only detects NO 2 Ϫ and NO 3 Ϫ that can readily pass into the gas phase to react with the O 3 in the microreaction purge vessel. Thus, any of the NO formed in vivo that would react with thiol groups in low-molecular-mass compounds is not detected here. 
statistical analysis
Unless otherwise stated, all data are expressed as the mean Ϯ SE of R. Global mean indicates the mean of all values of R calculated for each of the five agents with all concentrations of inorganic NO 2 Ϫ or NO 3 Ϫ used. The statistical analyses were done with the SAS statistical analysis program. The significance level was set at 0.05. The analysis of variance (GLM procedure) was used to compare values of global means (P 1 ) for the five reducing agents. The analysis was repeated for each amount of samples used (100 -500 pmol). The post hoc analysis between the five reducing agents was realized by using the Student-Newman-Keuls (SNK) tests. The effect of temperature and agents on R values was analyzed by using the two-way analysis of variance (P 2 ). The SNK post hoc analysis was used to compare R values for each agent at different temperatures and R values for different agents at the same temperature. The optimal reduction temperature(s) was (were) determined as the temperature(s) with the highest R value significantly different from the other R values. Separate paired t-tests were used for dog and pig plasma when the recovery of NO 2 Ϫ was compared with that of NO 3 Ϫ (P 3 ).
Results effect of different reducing agents on conversion of no 2 Ϫ to no at 20 Њc Analysis of variance indicated a difference on the global mean of the five agents (P 1 ϭ 0.0001). The post hoc analysis distinguished two groups: One, comprising Mo(VI) ϩ Fe(II) and Ti(III), had higher recovery rates than the second, comprising V(III), NaI, and Cr(III). The same two groups were identified for each amount (100 -500 pmol) of nitrite and nitrate. However, the difference between both groups was not statistically significant when the global mean values for the five reducing agents were compared. This analysis is summarized in Table 1 .
effect of temperature on conversion of 400 pmol of no 2 Ϫ to no
Temperature had no effect on the detection of NO gas by chemiluminescence (data not shown; P 1 ϭ 0.63). Recovery of NO from NO 2 Ϫ (P 2 ϭ 0.01) by the five reducing agents was affected by temperature (Fig. 2) effect of temperature on conversion of 400 pmol of no 3 Ϫ to no
Temperature affected the recovery of NO from NO 3 Ϫ by V(III), Mo(VI) ϩ Fe(II), and Ti(III) (P 2 ϭ 0.0001; Fig. 3 ). The optimal reduction temperature was 80 -90°C for V(III) and 70 -90°C for Mo(VI)ϩFe(II) and Ti(III). Temperature did not affect the low recovery (Ͻ1.7% at any temperature tested) of NO from NO 3 Ϫ by NaI or Cr(III).
recovery from plasma
For pig plasma, the recovery of NO 2 Ϫ was 96.4% Ϯ 1.9% (n ϭ 20) and the recovery of NO 3 Ϫ was 104.3% Ϯ 4.9% (n ϭ 20) over the entire concentration range tested (100 -500 pmol). There was no significant difference between the recovery of NO 2 Ϫ and NO 3 Ϫ (P 3 ϭ 0.21). For dog plasma, the recovery of NO 2 Ϫ was 89.6% Ϯ 2.0% (n ϭ 20) and the recovery of NO 3 Ϫ was 107.4% Ϯ 2.4% (n ϭ 20) over the entire concentration range tested (100 -500 pmol). The difference between the recovery of NO 2 Ϫ and NO 3 Ϫ was significant (P 3 ϭ 0.0008). Recoveries are expressed as relative percentages calculated from the area under the response curve from baseline to baseline of NO gas as 100.0% recovery (mean Ϯ SE).
Discussion
NO is a highly reactive messenger molecule that readily diffuses through plasmalemma to exert its biological activity in a variety of cells [5] . Several biological actions are attributed to NO via its activation of soluble guanylate cyclase, which catalyzes the transformation of GTP to cGMP. This transformation in turn activates a classical second messenger system that relays signals from the cell exterior to cell interior. Determination of increased NO formation is therefore of the utmost interest [3, 7, 9] .
Determination of NO in itself is difficult because of its free-radical nature and short half-life. NO reacts rapidly with oxygen to form NO 2 Ϫ and with superoxide or with oxyhemoglobin to form NO 3 Ϫ . In most cell culture systems [2] , NO will be oxidized primarily to NO 2 Ϫ , whereas in animal models and human samples, NO is oxidized both to NO 2 Ϫ and NO 3 Ϫ . Nitrite and nitrate are both stable in frozen plasma for at least 1 year [2] . Therefore, determination of the stable end products of the NO radical is most often used to measure its concentration. NO 3 Ϫ is the major metabolite of NO in blood [2] ; thus, determination of NO 2 Ϫ alone as a marker for NO concentration is meaningless, even if some previous studies had reported NO 2 Ϫ as the major byproduct of NO in blood [14] . The availability of a quantitative assay for both NO 2 Ϫ and NO 3 Ϫ can facilitate further elucidation of some of the physiological, pathophysiological, pharmacological, and therapeutic roles of NO.
Compared with other analytical methods [2] [3] [4] (e.g., spectrophotometry, electron paramagnetic resonance, gas or liquid chromatography, mass spectrometry), chemiluminescence is highly sensitive, selective, and accurate for NO 2 Ϫ and (or) NO 3 Ϫ , especially at the low concentrations in complex matrices found in water, food, and biological fluids. The key point in this procedure is to choose the Ϫ to NO by the five reducing agents.
Each point was determined from three separate experiments, and triplicate measurements were made for each sample. Recoveries expressed as percentage based on the area under the response curve from baseline to baseline of NO gas as 100.0% recovery (mean Ϯ SE). ND ϭ not detectable. Fig. 3 . Effect of temperature on conversion of 400 pmol of NO 3 Ϫ to NO by the five reducing agents.
Each point was determined from three separate experiments, and triplicate measurements were made for each sample.
appropriate reducing agent/temperature combination to selectively and completely reduce NO 2 Ϫ or NO 3 Ϫ to NO. Several reducing agents have been tested for the reduction of NO 2 Ϫ and (or) NO 3 Ϫ to NO, such as NaI for the conversion of NO 2 Ϫ to NO, and V(III), Mo(VI) ϩ Fe(II), Ti(III), and Cr(II) for the conversion of NO 3 Ϫ to NO [5, 9 -13] . NO 2 Ϫ can be reduced to NO by using most reducing agents at room temperature, whereas conversion of NO 3 Ϫ to NO requires both a strong reducing agent and high temperature. V(III) and Ti(III) with three valences can reduce most of NO 3 Ϫ to NO at high temperature. We compared the efficiency of Cr(III), also with three valences, with V(III) and Ti(III) for the conversion of NO 2 Ϫ or NO 3 Ϫ to NO. Our work revealed that the five reducing agents have a similar efficiency for the conversion of NO 2 Ϫ to NO at 20°C, with a slight advantage for Mo(VI) ϩ Fe(II) and Ti(III) over the other three agents. The recovery of NO from NO 2 Ϫ was almost complete, compared with the known amount of NO gas standard [lower R value: 86.2% Ϯ 1.6% for Cr(III) for the recovery of 100 pmol of NO 2 Ϫ ]. V(III) and Mo(VI)ϩFe(II) were equally efficient in converting NO 3 Ϫ to NO at 80°C, and recovery of NO was nearly complete. However, recovery with Ti(III) was lower. NaI and Cr(III) were unable to reduce NO 3 Ϫ to NO, as only trace amounts of NO were recovered from NO 3 Ϫ regardless of the amount of NO 3 Ϫ and the temperature used. NaI and Cr(III) can thus be considered selective for reducing NO 2 Ϫ to NO. To our knowledge, this is the first report to show that Cr(III) can selectively reduce NO 2 Ϫ to NO. Enzymatic reduction of NO 3 Ϫ by using an immobilized Escherichia coli nitrate reductase column [15] converts ϳ30% of NO 3 Ϫ to NO 2 Ϫ . Another assay based on the coupled oxidation of NADPH during the enzymatic conversion of NO 3 Ϫ to NO 2 Ϫ by Aspergillus nitrate reductase only yields ϳ64% of serum NO 3 Ϫ to NO 2 Ϫ and is unsatisfactory for NO 3 Ϫ analysis in serum samples. Furthermore, though many reports claim a possible recovery of 100%, commercial nitrate reductases are rather expensive [16] . Powerful chemical reducing agents such as V(III), Mo(VI) ϩ Fe(II), and to a lesser degree Ti(III) are more efficient than nitrate reductases for converting NO 3 Ϫ to NO 2 Ϫ in biological samples. The temperature affected the conversion of both NO 2 Ϫ and NO 3 Ϫ to NO, as the reduction process is facilitated and more rapid at higher temperatures. This is particularly true for the conversion of NO 3 Ϫ to NO. However, increasing temperature had several technical drawbacks on the conversion of NO 2 Ϫ and NO 3 Ϫ to NO. The first is that the measurement of NO by chemiluminescence is influenced by humidity [3, 4] . As temperature increased, the heat evaporated more water, which quenched NO 2 * produced by the O 3 reaction. The second problem encountered is that the reducing solution has a tendency to move from the microreaction purge vessel to the condenser and even to the NO analyzer itself at high temperatures. We therefore propose that 60°C would be the really appropriate temperature for converting NO 2 Ϫ to NO by these five reducing agents. In the case of NaI, the most efficient NO 2 Ϫ reducing agent at any temperature, increasing the temperature had the undesirable effect of increasing the variability of the results (larger SE) and lowering the reproducibility, because of the above-mentioned reasons. The same situation was observed for the conversion of NO 3 Ϫ to NO. It would thus be very useful to find and select a reducing agent that can reduce NO 3 Ϫ to NO at low temperatures.
It has been suggested that strong reducing agents, such as V(III), can be used at different temperatures to achieve different goals: at low temperatures for the conversion of NO 2 Ϫ to NO, and at high temperatures for the conversion of NO 2 Ϫ ϩ NO 3 Ϫ to NO. NO 3 Ϫ would then be determined by the difference between analysis of the same sample by both assays. Fig. 3 shows that V(III), Mo(VI) ϩ Fe(II), and Ti(III) can also reduce NO 3 Ϫ to NO at low temperature, albeit at a low degree. Use of only two different temperatures cycling for a strong reducing agent to selectively reduce NO 2 Ϫ and (or) NO 3 Ϫ to NO can be a cause of overestimated NO 2 Ϫ and underestimated NO 3 Ϫ measurements.
Our results indicate that the most accurate procedure is to use NaI or Cr(III) as a reducing agent to selectively convert NO 2 Ϫ to NO at low temperatures and then use a strong reducing agent to convert all NO 2 Ϫ ϩ NO 3 Ϫ to NO at 80°C or 90°C.
Proteins contained in most biological samples can cause excessive foaming in the microreaction purge vessel and interfere with the reduction process. Deproteinization is therefore essential for the analysis of such samples. Investigating the recovery of both NO 2 Ϫ and NO 3 Ϫ in biological samples with particular attention given to the reproducibility of the assay and the occurrence of artifacts is important. In this study, recovery of NO 2 Ϫ and NO 3 Ϫ in deproteinized plasma was 93.0% Ϯ 1.6% and 105.9% Ϯ 2.7% respectively. Although the recoveries of NO 2 Ϫ and NO 3 Ϫ were similar and complete for the pig plasma, we discovered a small but significant difference in the case of the dog plasma. The residual protein environment in the dog plasma seemed to interfere more with NO 2 Ϫ than with NO 3 Ϫ . Though part of the NO formed in vivo may react with thiol groups in low-molecular-mass compounds, this method does not detect these low-molecularmass nitroso compounds, as NO must be in the gas state to react with the O 3 in the reaction chamber.
Compared with the same amount of NO gas, V(III), Mo(VI) ϩ Fe(II), NaI, Ti(III), and Cr(III) are similarly efficient reducing agents for the conversion of NO 2 Ϫ to NO at 20°C. V(III) and Mo(VI) ϩ Fe(II) can also completely reduce NO 3 Ϫ to NO at high temperatures. However, Cr(III) and NaI were unable to convert NO 3 Ϫ to NO. Cr(III) and NaI can specifically reduce NO 2 Ϫ to NO. We recommend the use of NaI or Cr(III) at room temperature to selectively and completely reduce NO 2 Ϫ and the use of V(III) or Mo(VI) ϩ Fe(II) at 80 -90°C to reduce NO 2 Ϫ ϩ Clinical Chemistry 43, No. 4, 1997 NO 3 Ϫ to NO. Recovery of both NO 2 Ϫ and NO 3 Ϫ in experimental animal plasma was reproducible and near quantitative, albeit to a lesser degree in the case of the dog plasma. These results also highlight the need for a relatively large-scale study with human subjects to establish proper baseline measurements for clinical assays of plasma nitrite and nitrate concentrations.
We estimate that a properly organized clinical laboratory could process ϳ30 samples/h for NO 2 measurements and ϳ15 samples/h for the measurement of NO 3 concentrations.
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